The Battle Between Two $1B+ Biotech Unicorns Post author:Sam Post published:November 5, 2017 Post category:BioPharma Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics. Source: BioSpace You Might Also Like Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017 CryoPort Announces Proposed Public Offering Of Common Stock March 27, 2017 <b>eSight</b> 3 Launches In Europe June 22, 2017
Bay Area's Portola Rockets as the FDA Approves First and Only Anticoagulant for Hospitals June 25, 2017